Jude Onyia, Chief Scientific Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 9,016 shares at $102.30 ($922K) on 2023-02-07, disclosed to the SEC on 2023-02-08.
Open-market sale of $922k NBIX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $102.30 | 4,508 | $461K | 50.0% |
| 2 | $102.30 | 4,508 | $461K | 50.0% |
| Total | $102.30 avg | 9,016 | $922K | 100% |
| Filing → |
| NBIX | SELL | 2025-07-11 | $15.6M | — | Filing → |
| NBIX | SELL | 2025-07-07 | $5.3M | — | Filing → |
| NBIX | SELL | 2025-02-14 | $672K | — | Filing → |